Karin Hamberg
Direktor/Vorstandsmitglied bei LEO Holding A/S (Denmark)
Profil
Karin Jexner Hamberg is currently a Director at LEO Holding A since 2019.
She was previously the Chief Medical Officer & Executive Vice President at Veloxis Pharmaceuticals A in 2009.
She holds a doctorate degree from the University of Copenhagen.
Aktive Positionen von Karin Hamberg
| Unternehmen | Position | Beginn |
|---|---|---|
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | 27.02.2019 |
Ehemalige bekannte Positionen von Karin Hamberg
| Unternehmen | Position | Ende |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Technik-/Wissenschafts-/F&E-Leiter | 15.04.2009 |
Ausbildung von Karin Hamberg
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
LEO Holding A/S (Denmark)
LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Finance |
